Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	lead ion binding	PLSCR3 PLSCR1	1.59e-04	3	146	2	GO:0032791
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH3 DYNC2H1 DNAH14	2.88e-04	18	146	3	GO:0008569
GeneOntologyMolecularFunction	lamin binding	SYNE1 PLCB1 DMD	3.41e-04	19	146	3	GO:0005521
Domain	Spectrin_repeat	SYNE1 EVPL ACTN4 DMD	7.31e-05	29	146	4	IPR002017
Domain	SPEC	SYNE1 EVPL ACTN4 DMD	1.09e-04	32	146	4	SM00150
Domain	Spectrin/alpha-actinin	SYNE1 EVPL ACTN4 DMD	1.09e-04	32	146	4	IPR018159
Domain	Dynein_heavy_chain_D4_dom	DNAH3 DYNC2H1 DNAH14	1.60e-04	14	146	3	IPR024317
Domain	Dynein_HC_stalk	DNAH3 DYNC2H1 DNAH14	1.60e-04	14	146	3	IPR024743
Domain	MT	DNAH3 DYNC2H1 DNAH14	1.60e-04	14	146	3	PF12777
Domain	AAA_8	DNAH3 DYNC2H1 DNAH14	1.60e-04	14	146	3	PF12780
Domain	EST1	SMG5 SMG7	1.81e-04	3	146	2	PF10374
Domain	EST1_DNA_bind	SMG5 SMG7	1.81e-04	3	146	2	PF10373
Domain	EST1	SMG5 SMG7	1.81e-04	3	146	2	IPR019458
Domain	DNA/RNA-bd_Est1-type	SMG5 SMG7	1.81e-04	3	146	2	IPR018834
Domain	DHC_fam	DNAH3 DYNC2H1 DNAH14	1.99e-04	15	146	3	IPR026983
Domain	Dynein_heavy	DNAH3 DYNC2H1 DNAH14	1.99e-04	15	146	3	PF03028
Domain	Dynein_heavy_dom	DNAH3 DYNC2H1 DNAH14	1.99e-04	15	146	3	IPR004273
Domain	ARM-like	CUL9 RICTOR ZYG11B HEATR1 TEX10 HEATR6 NBEAL2 TAF7L STAG3	2.78e-04	270	146	9	IPR011989
Domain	ARM-type_fold	CUL9 RICTOR ZYG11B APOB HEATR1 TEX10 LYST HEATR6 NBEAL2 STAG3	3.40e-04	339	146	10	IPR016024
Domain	SHR-BD	VPS13D VPS13B	3.60e-04	4	146	2	IPR009543
Domain	STAG	STAG3L4 STAG3	3.60e-04	4	146	2	PF08514
Domain	STAG	STAG3L4 STAG3	3.60e-04	4	146	2	IPR013721
Domain	VPS13_C	VPS13D VPS13B	3.60e-04	4	146	2	PF16909
Domain	VPS13_C	VPS13D VPS13B	3.60e-04	4	146	2	IPR031645
Domain	SHR-BD	VPS13D VPS13B	3.60e-04	4	146	2	PF06650
Domain	Scramblase	PLSCR3 PLSCR1	5.98e-04	5	146	2	PF03803
Domain	Scramblase	PLSCR3 PLSCR1	5.98e-04	5	146	2	IPR005552
Domain	Spectrin	SYNE1 ACTN4 DMD	7.39e-04	23	146	3	PF00435
Domain	ACTININ_2	SYNE1 ACTN4 DMD	7.39e-04	23	146	3	PS00020
Domain	ACTININ_1	SYNE1 ACTN4 DMD	7.39e-04	23	146	3	PS00019
Domain	Actinin_actin-bd_CS	SYNE1 ACTN4 DMD	7.39e-04	23	146	3	IPR001589
Domain	PH_BEACH	LYST NBEAL2	8.92e-04	6	146	2	PF14844
Domain	EF-hand_dom_typ1	DTNA DMD	8.92e-04	6	146	2	IPR015153
Domain	EF-hand_dom_typ2	DTNA DMD	8.92e-04	6	146	2	IPR015154
Domain	EF-hand_2	DTNA DMD	8.92e-04	6	146	2	PF09068
Domain	EF-hand_3	DTNA DMD	8.92e-04	6	146	2	PF09069
Domain	-	DTNA CAPN2 ACTN4 STAT5A STAT5B SLC25A13 PLCB1 DMD	1.05e-03	261	146	8	1.10.238.10
Domain	STAT_TF_DNA-bd_sub	STAT5A STAT5B	1.24e-03	7	146	2	IPR012345
Domain	STAT	STAT5A STAT5B	1.24e-03	7	146	2	IPR001217
Domain	APC_su10/DOC_dom	CUL9 ANAPC10	1.24e-03	7	146	2	IPR004939
Domain	STAT_int	STAT5A STAT5B	1.24e-03	7	146	2	SM00964
Domain	STAT_TF_DNA-bd	STAT5A STAT5B	1.24e-03	7	146	2	IPR013801
Domain	STAT_bind	STAT5A STAT5B	1.24e-03	7	146	2	PF02864
Domain	STAT_int	STAT5A STAT5B	1.24e-03	7	146	2	PF02865
Domain	DOC	CUL9 ANAPC10	1.24e-03	7	146	2	PS51284
Domain	-	STAT5A STAT5B	1.24e-03	7	146	2	1.10.532.10
Domain	STAT_alpha	STAT5A STAT5B	1.24e-03	7	146	2	PF01017
Domain	-	STAT5A STAT5B	1.24e-03	7	146	2	1.20.1050.20
Domain	ANAPC10	CUL9 ANAPC10	1.24e-03	7	146	2	PF03256
Domain	STAT_TF_prot_interaction	STAT5A STAT5B	1.24e-03	7	146	2	IPR013799
Domain	STAT_TF_coiled-coil	STAT5A STAT5B	1.24e-03	7	146	2	IPR015988
Domain	-	STAT5A STAT5B	1.24e-03	7	146	2	2.60.40.630
Domain	APC10	CUL9 ANAPC10	1.24e-03	7	146	2	SM01337
Domain	RhoGAP	ARHGAP10 ARHGAP17 ARHGAP31 SYDE2	1.41e-03	62	146	4	SM00324
Domain	RhoGAP	ARHGAP10 ARHGAP17 ARHGAP31 SYDE2	1.49e-03	63	146	4	PF00620
Domain	RhoGAP_dom	ARHGAP10 ARHGAP17 ARHGAP31 SYDE2	1.58e-03	64	146	4	IPR000198
Domain	RHOGAP	ARHGAP10 ARHGAP17 ARHGAP31 SYDE2	1.58e-03	64	146	4	PS50238
Domain	-	ARHGAP10 ARHGAP17 ARHGAP31 SYDE2	1.58e-03	64	146	4	1.10.555.10
Domain	STAT_TF_alpha	STAT5A STAT5B	1.65e-03	8	146	2	IPR013800
Domain	Chorein_N	VPS13D VPS13B	1.65e-03	8	146	2	PF12624
Domain	PH-BEACH_dom	LYST NBEAL2	1.65e-03	8	146	2	IPR023362
Domain	VPS13_N	VPS13D VPS13B	1.65e-03	8	146	2	IPR026854
Domain	-	LYST NBEAL2	1.65e-03	8	146	2	2.30.29.40
Domain	PH_BEACH	LYST NBEAL2	1.65e-03	8	146	2	PS51783
Domain	-	CUL9 RICTOR ZYG11B HEATR1 TEX10 HEATR6 STAG3	1.83e-03	222	146	7	1.25.10.10
Domain	EF-hand-dom_pair	DTNA CAPN2 ACTN4 STAT5A STAT5B SLC25A13 PLCB1 DMD	1.91e-03	287	146	8	IPR011992
Domain	BEACH	LYST NBEAL2	2.11e-03	9	146	2	PS50197
Domain	Beach	LYST NBEAL2	2.11e-03	9	146	2	PF02138
Domain	-	LYST NBEAL2	2.11e-03	9	146	2	1.10.1540.10
Domain	Beach	LYST NBEAL2	2.11e-03	9	146	2	SM01026
Domain	BEACH_dom	LYST NBEAL2	2.11e-03	9	146	2	IPR000409
Domain	CH	SYNE1 ACTN4 MAPRE3 DMD	2.20e-03	70	146	4	PF00307
Domain	-	SYNE1 ACTN4 MAPRE3 DMD	2.32e-03	71	146	4	1.10.418.10
Domain	CH	SYNE1 ACTN4 MAPRE3 DMD	2.57e-03	73	146	4	PS50021
Domain	CH-domain	SYNE1 ACTN4 MAPRE3 DMD	2.83e-03	75	146	4	IPR001715
Domain	6-hairpin_glycosidase-like	GBA2 PHKA1	4.47e-03	13	146	2	IPR008928
Domain	Rho_GTPase_activation_prot	ARHGAP10 ARHGAP17 ARHGAP31 SYDE2	5.03e-03	88	146	4	IPR008936
Domain	Dynein_heavy_dom-2	DNAH3 DYNC2H1	5.19e-03	14	146	2	IPR013602
Domain	DHC_N2	DNAH3 DYNC2H1	5.19e-03	14	146	2	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH3 DYNC2H1	5.19e-03	14	146	2	IPR011704
Domain	AAA_5	DNAH3 DYNC2H1	5.19e-03	14	146	2	PF07728
Domain	ConA-like_dom	TMPRSS15 LAMA2 MMRN1 THBS2 NBEAL2 SLIT3	7.56e-03	219	146	6	IPR013320
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	EMC1 ARHGAP10 DTNA CEP162 POLR2E CCDC18 NUP98 RICTOR ACTN4 ZYG11B TEX10 SHOC2 PHKA1 PTPRC NUP155 SMG7 PTPRG WASHC5 CEP135 DMD DNMT1	5.44e-09	1049	150	21	27880917
Pubmed	Fetal and neonatal hematopoietic progenitors are functionally and transcriptionally resistant to Flt3-ITD mutations.	RICTOR STAT5A STAT5B PTPRC	2.30e-08	8	150	4	27879203
Pubmed	Stat5 opposes the transcription factor Tox and rewires exhausted CD8+ T cells toward durable effector-like states during chronic antigen exposure.	STAT5A STAT5B PTPRC	7.86e-08	3	150	3	38091951
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	LCA5 CCP110 DYNC2H1 ARHGAP10 TCP11L1 POLR2E CDH23 ACTN4 ZYG11B HEATR1 NDUFA5 SHOC2 NEK9 LSM1 MAPRE3 EXOC5 PTPRG TTC21B TXLNG SNRNP200 PMFBP1	2.68e-07	1321	150	21	27173435
Pubmed	Characterization of size-fractionated cDNA libraries generated by the in vitro recombination-assisted method.	DYNC2H1 RICTOR NEK9 TTC21B	4.37e-07	15	150	4	12056414
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	CHERP LRRC24 DYNC2H1 PSKH1 SYNE1 POLR2E APOB HEATR1 SLC9A2 NR1I2 SLC25A13 DMD TXLNG SNRNP200 STAG3	1.04e-06	754	150	15	35906200
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	DHX16 KNTC1 CHERP SYNE1 TCP11L1 NUP98 TFIP11 SHOC2 NEK9 TASOR2 ANAPC10 NUP155 GTF3C1 WASHC5 CEP135 GPC5 SNRNP200 VPS13B	2.71e-06	1155	150	18	20360068
Pubmed	Cytoplasmic gamma-actin expression in diverse animal models of muscular dystrophy.	DTNA LAMA2 DMD	2.72e-06	7	150	3	17475492
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	KNTC1 SCN11A DTNA PPFIA4 SYNE1 NUP98 ACTN4 APOB HEATR1 PPARA NDUFA5 TEX10 LYST TASOR2 GTF3C1 SLC25A13 UGP2 JAKMIP1 DMD CCDC158	4.23e-06	1442	150	20	35575683
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	DHX16 EMC1 NRDC GRB7 RICTOR TFIP11 INTS3 STAT5B NUP155 GTF3C1 WASHC5 KYNU DNMT1	5.32e-06	650	150	13	38777146
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	DHX16 CHERP NUP98 CUL9 ACTN4 HEATR1 TEX10 TASOR2 NUP155 GTF3C1 SLC25A13 SNRNP200 DNMT1	5.59e-06	653	150	13	22586326
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	EPS8 DTNA RICTOR SLITRK3 APOB PTPRG ARHGAP31 NBEAL2 PLCB1 PLSCR3 TXLNG VPS13B	7.31e-06	569	150	12	30639242
Pubmed	A human MAP kinase interactome.	SYNE1 NUP98 ARHGAP17 EVPL ACTN4 ARHGAP31 PLCB1 MAP3K10 DMD TXLNG SNRNP200	9.23e-06	486	150	11	20936779
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KNTC1 CCP110 DYNC2H1 PPFIA4 RICTOR GBA2 NEK9 VPS13D CEP135 TTC21B SNRNP200	1.05e-05	493	150	11	15368895
Pubmed	Phospho-tyrosine dependent protein-protein interaction network.	EPS8 ARHGAP10 DTNA GRB7 PPARA ZBTB24 STAT5A TASOR2 MAPRE3 ANAPC10	1.26e-05	410	150	10	25814554
Pubmed	Definitive evidence using enucleated cytoplasts for a nongenomic basis for the cystic change in endoplasmic reticulum structure caused by STAT5a/b siRNAs.	STAT5A STAT5B	1.85e-05	2	150	2	23151802
Pubmed	Signal transducer and activator of transcription 5 (STAT5) paralog dose governs T cell effector and regulatory functions.	STAT5A STAT5B	1.85e-05	2	150	2	26999798
Pubmed	GADD45α inhibition of DNMT1 dependent DNA methylation during homology directed DNA repair.	GADD45A DNMT1	1.85e-05	2	150	2	22135303
Pubmed	A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions.	STAT5A STAT5B	1.85e-05	2	150	2	31443474
Pubmed	Extended tropism of an adenoviral vector does not circumvent the maturation-dependent transducibility of mouse skeletal muscle.	LAMA2 DMD	1.85e-05	2	150	2	10753064
Pubmed	Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.	STAT5A STAT5B	1.85e-05	2	150	2	12377952
Pubmed	Mobilization of pro-inflammatory lipids in obese Plscr3-deficient mice.	PLSCR3 PLSCR1	1.85e-05	2	150	2	17355638
Pubmed	A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development.	STAT5A STAT5B	1.85e-05	2	150	2	21127177
Pubmed	The gammac-cytokine regulated transcription factor, STAT5, increases HIV-1 production in primary CD4 T cells.	STAT5A STAT5B	1.85e-05	2	150	2	16289657
Pubmed	Inhibition of Stat5a/b Enhances Proteasomal Degradation of Androgen Receptor Liganded by Antiandrogens in Prostate Cancer.	STAT5A STAT5B	1.85e-05	2	150	2	25552366
Pubmed	Deletion of STAT5a/b in vascular smooth muscle abrogates the male bias in hypoxic pulmonary hypertension in mice: implications in the human disease.	STAT5A STAT5B	1.85e-05	2	150	2	25470773
Pubmed	Constitutively active Stat5A and Stat5B promote adipogenesis.	STAT5A STAT5B	1.85e-05	2	150	2	21431790
Pubmed	Stat5 Is Required for CD103+ Dendritic Cell and Alveolar Macrophage Development and Protection from Lung Injury.	STAT5A STAT5B	1.85e-05	2	150	2	28500076
Pubmed	STAT5 isoforms regulate colorectal cancer cell apoptosis via reduction of mitochondrial membrane potential and generation of reactive oxygen species.	STAT5A STAT5B	1.85e-05	2	150	2	21826656
Pubmed	Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs.	STAT5A STAT5B	1.85e-05	2	150	2	7720707
Pubmed	STAT5A and STAT5B have opposite correlations with drug response gene expression.	STAT5A STAT5B	1.85e-05	2	150	2	27264955
Pubmed	Analysis of dystrophin in fast- and slow-twitch skeletal muscles from mdx and dy2J mice at different ages.	LAMA2 DMD	1.85e-05	2	150	2	2183046
Pubmed	Nongenomic STAT5-dependent effects on Golgi apparatus and endoplasmic reticulum structure and function.	STAT5A STAT5B	1.85e-05	2	150	2	22159083
Pubmed	STAT5 requires the N-domain for suppression of miR15/16, induction of bcl-2, and survival signaling in myeloproliferative disease.	STAT5A STAT5B	1.85e-05	2	150	2	20008792
Pubmed	STAT5 Regulation of Sex-Dependent Hepatic CpG Methylation at Distal Regulatory Elements Mapping to Sex-Biased Genes.	STAT5A STAT5B	1.85e-05	2	150	2	33199496
Pubmed	Reducing GBA2 Activity Ameliorates Neuropathology in Niemann-Pick Type C Mice.	NPC1 GBA2	1.85e-05	2	150	2	26275242
Pubmed	Quantitative morphology of mast cells in skeletal muscle of normal and genetically dystrophic mice.	LAMA2 DMD	1.85e-05	2	150	2	9066911
Pubmed	The influence of STAT5 antisense oligodeoxynucleotides on the proliferation and apoptosis of selected human cutaneous T-cell lymphoma cell lines.	STAT5A STAT5B	1.85e-05	2	150	2	16502315
Pubmed	Stat5: an essential regulator of mast cell biology.	STAT5A STAT5B	1.85e-05	2	150	2	12217382
Pubmed	Brain STAT5 Modulates Long-Term Metabolic and Epigenetic Changes Induced by Pregnancy and Lactation in Female Mice.	STAT5A STAT5B	1.85e-05	2	150	2	31599926
Pubmed	DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites.	STAT5A STAT5B	1.85e-05	2	150	2	10594041
Pubmed	Mitochondrial translocation of signal transducer and activator of transcription 5 (STAT5) in leukemic T cells and cytokine-stimulated cells.	STAT5A STAT5B	1.85e-05	2	150	2	21036145
Pubmed	Stimulation of lipolysis but not of leptin release by growth hormone is abolished in adipose tissue from Stat5a and b knockout mice.	STAT5A STAT5B	1.85e-05	2	150	2	10486277
Pubmed	Role of PPAR, LXR, and PXR in epidermal homeostasis and inflammation.	PPARA NR1I2	1.85e-05	2	150	2	24315978
Pubmed	Identification of human STAT5-dependent gene regulatory elements based on interspecies homology.	STAT5A STAT5B	1.85e-05	2	150	2	16840779
Pubmed	The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells.	STAT5A STAT5B	1.85e-05	2	150	2	15128421
Pubmed	STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice.	STAT5A STAT5B	1.85e-05	2	150	2	30377054
Pubmed	Gain-of-function of Stat5 leads to excessive granulopoiesis and lethal extravasation of granulocytes to the lung.	STAT5A STAT5B	1.85e-05	2	150	2	23565285
Pubmed	Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer.	STAT5A STAT5B	1.85e-05	2	150	2	32790723
Pubmed	Laminin-alpha2 but not -alpha1-mediated adhesion of human (Duchenne) and murine (mdx) dystrophic myotubes is seriously defective.	LAMA2 DMD	1.85e-05	2	150	2	9188790
Pubmed	In vivo identification of novel STAT5 target genes.	STAT5A STAT5B	1.85e-05	2	150	2	18492722
Pubmed	Distinctive roles of STAT5a and STAT5b in sexual dimorphism of hepatic P450 gene expression. Impact of STAT5a gene disruption.	STAT5A STAT5B	1.85e-05	2	150	2	10066807
Pubmed	Molecular characterization of STAT5A- and STAT5B-encoding genes reveals extended intragenic sequence homogeneity in cattle and mouse and different degrees of divergent evolution of various domains.	STAT5A STAT5B	1.85e-05	2	150	2	10835485
Pubmed	Loss of Adipocyte STAT5 Confers Increased Depot-Specific Adiposity in Male and Female Mice That Is Not Associated With Altered Adipose Tissue Lipolysis.	STAT5A STAT5B	1.85e-05	2	150	2	35464049
Pubmed	Loss of cytokine-STAT5 signaling in the CNS and pituitary gland alters energy balance and leads to obesity.	STAT5A STAT5B	1.85e-05	2	150	2	18286195
Pubmed	Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells.	STAT5A STAT5B	1.85e-05	2	150	2	23773921
Pubmed	Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells.	STAT5A STAT5B	1.85e-05	2	150	2	8631883
Pubmed	Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2.	STAT5A STAT5B	1.85e-05	2	150	2	11030348
Pubmed	Association between STAT5 polymorphisms and glioblastoma risk in Han Chinese population.	STAT5A STAT5B	1.85e-05	2	150	2	24878107
Pubmed	Regulation of eosinophil apoptosis by nitric oxide: Role of c-Jun-N-terminal kinase and signal transducer and activator of transcription 5.	STAT5A STAT5B	1.85e-05	2	150	2	12847485
Pubmed	Stat5 synergizes with T cell receptor/antigen stimulation in the development of lymphoblastic lymphoma.	STAT5A STAT5B	1.85e-05	2	150	2	12835478
Pubmed	Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue.	STAT5A STAT5B	1.85e-05	2	150	2	7568026
Pubmed	Identification of STAT5A and STAT5B target genes in human T cells.	STAT5A STAT5B	1.85e-05	2	150	2	24497979
Pubmed	Role of STAT5a in regulation of sex-specific gene expression in female but not male mouse liver revealed by microarray analysis.	STAT5A STAT5B	1.85e-05	2	150	2	17536022
Pubmed	STAT5 transcriptional activity is impaired by LIF in a mammary epithelial cell line.	STAT5A STAT5B	1.85e-05	2	150	2	17382296
Pubmed	STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferation.	STAT5A STAT5B	1.85e-05	2	150	2	17911616
Pubmed	STAT5 signaling in sexually dimorphic gene expression and growth patterns.	STAT5A STAT5B	1.85e-05	2	150	2	10486314
Pubmed	The transcription factors Stat5a/b are not required for islet development but modulate pancreatic beta-cell physiology upon aging.	STAT5A STAT5B	1.85e-05	2	150	2	17599554
Pubmed	MiR-21 is under control of STAT5 but is dispensable for mammary development and lactation.	STAT5A STAT5B	1.85e-05	2	150	2	24497923
Pubmed	Constitutive activation of STAT5A and STAT5B regulates IgM secretion in Waldenstrom's macroglobulinemia.	STAT5A STAT5B	1.85e-05	2	150	2	24335105
Pubmed	Brain STAT5 signaling modulates learning and memory formation.	STAT5A STAT5B	1.85e-05	2	150	2	29460051
Pubmed	STAT5 deletion in macrophages alters ductal elongation and branching during mammary gland development.	STAT5A STAT5B	1.85e-05	2	150	2	28606561
Pubmed	Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells.	STAT5A STAT5B	1.85e-05	2	150	2	12393407
Pubmed	The structure of human STAT5A and B genes reveals two regions of nearly identical sequence and an alternative tissue specific STAT5B promoter.	STAT5A STAT5B	1.85e-05	2	150	2	12039059
Pubmed	Differential changes in responses of hypothalamic and brainstem neuronal populations to prolactin during lactation in the mouse.	STAT5A STAT5B	1.85e-05	2	150	2	21178171
Pubmed	Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo.	STAT5A STAT5B	1.85e-05	2	150	2	20233708
Pubmed	Involvement of the STAT5 signaling pathway in the regulation of mouse preimplantation development.	STAT5A STAT5B	1.85e-05	2	150	2	16775227
Pubmed	STAT5 isoforms: controversies and clarifications.	STAT5A STAT5B	1.85e-05	2	150	2	17447893
Pubmed	SMG7 acts as a molecular link between mRNA surveillance and mRNA decay.	SMG5 SMG7	1.85e-05	2	150	2	15546618
Pubmed	Epigenetic dysregulation in salivary glands from patients with primary Sjögren's syndrome may be ascribed to infiltrating B cells.	GADD45A DNMT1	1.85e-05	2	150	2	23478041
Pubmed	Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrence.	STAT5A STAT5B	1.85e-05	2	150	2	16115927
Pubmed	Sequential activation of genetic programs in mouse mammary epithelium during pregnancy depends on STAT5A/B concentration.	STAT5A STAT5B	1.85e-05	2	150	2	23275557
Pubmed	Granulocyte-macrophage colony-stimulating factor (GM-CSF)-induced STAT5 activation and target-gene expression during human monocyte/macrophage differentiation.	STAT5A STAT5B	1.85e-05	2	150	2	11867689
Pubmed	Global analysis of IL-2 target genes: identification of chromosomal clusters of expressed genes.	STAT5A STAT5B	1.85e-05	2	150	2	15980098
Pubmed	Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation.	STAT5A STAT5B	1.85e-05	2	150	2	15340066
Pubmed	Glucocerebrosidases catalyze a transgalactosylation reaction that yields a newly-identified brain sterol metabolite, galactosylated cholesterol.	NPC1 GBA2	1.85e-05	2	150	2	32144204
Pubmed	Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3).	PLSCR3 PLSCR1	1.85e-05	2	150	2	15328404
Pubmed	STAT5A/B gene locus undergoes amplification during human prostate cancer progression.	STAT5A STAT5B	1.85e-05	2	150	2	23660011
Pubmed	Absence of glial α-dystrobrevin causes abnormalities of the blood-brain barrier and progressive brain edema.	DTNA DMD	1.85e-05	2	150	2	23043099
Pubmed	Role of Stat5 in type I interferon-signaling and transcriptional regulation.	STAT5A STAT5B	1.85e-05	2	150	2	12901872
Pubmed	The carboxyl tail of alpha-actinin-4 regulates its susceptibility to m-calpain and thus functions in cell migration and spreading.	CAPN2 ACTN4	1.85e-05	2	150	2	23466492
Pubmed	O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies.	STAT5A STAT5B	1.85e-05	2	150	2	28074064
Pubmed	STAT5b: A master regulator of key biological pathways.	STAT5A STAT5B	1.85e-05	2	150	2	36755813
Pubmed	Identification of isoform-specific dynamics in phosphorylation-dependent STAT5 dimerization by quantitative mass spectrometry and mathematical modeling.	STAT5A STAT5B	1.85e-05	2	150	2	25333863
Pubmed	A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance.	STAT5A STAT5B	1.85e-05	2	150	2	12421978
Pubmed	A single amino acid in the DNA binding regions of STAT5A and STAT5B confers distinct DNA binding specificities.	STAT5A STAT5B	1.85e-05	2	150	2	9852045
Pubmed	Signal transducer and activator of transcription (STAT)-5A and STAT5B differentially regulate human mammary carcinoma cell behavior.	STAT5A STAT5B	1.85e-05	2	150	2	19966185
Pubmed	Signal transducer and activator of transcription 5a/b: biomarker and therapeutic target in prostate and breast cancer.	STAT5A STAT5B	1.85e-05	2	150	2	21704724
Pubmed	Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia.	STAT5A STAT5B	1.85e-05	2	150	2	38618957
Pubmed	SMG5-SMG7 authorize nonsense-mediated mRNA decay by enabling SMG6 endonucleolytic activity.	SMG5 SMG7	1.85e-05	2	150	2	34172724
Interaction	CCDC66 interactions	LCA5 CEP162 ANKRD36B MAPRE3 CEP135	3.10e-06	32	145	5	int:CCDC66
Cytoband	2q11.2	ANKRD36B SLC9A2 VWA3B SNRNP200	9.48e-05	72	150	4	2q11.2
GeneFamily	Phospholipid scramblases	PLSCR3 PLSCR1	2.59e-04	5	93	2	954
GeneFamily	Cohesin complex	STAG3 SMC1B	7.18e-04	8	93	2	1060
GeneFamily	WD repeat domain containing\|BEACH domain containing	LYST NBEAL2	9.20e-04	9	93	2	1230
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	ARHGAP10 ARHGAP17 ARHGAP31	2.17e-03	50	93	3	721
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_1000	NRBP1 CCDC18 TASOR2 EXOC5 TAF7L USP40 TXLNG STAG3 CCDC158	1.62e-05	210	147	9	gudmap_developingGonad_e14.5_ ovary_1000_k1
ToppCell	droplet-Marrow-nan-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 SYNE1 NFKBIZ LYST GADD45A ELOVL7 RLF PTPRC	1.28e-07	172	150	8	d354424c1f861b6607dfd63b9724f4c237b30275
ToppCell	normal_Lymph_Node-Myeloid_cells-Activated_DCs\|Myeloid_cells / Location, Cell class and cell subclass	SCN11A ARHGAP10 CYTH1 LYST GADD45A COMMD2 CEP135 PDCD1LG2	3.10e-07	193	150	8	024d30eb143d8278c0851c3a6c9426226fa3b480
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rxfp1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SCN11A GRB7 GADD45A MMRN1 KCNJ5 KYNU PMFBP1	3.14e-07	131	150	7	81efe8b0ca4377e557a42ddb12aecaf3f46b15bf
ToppCell	facs-Lung-Endomucin-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AP1S3 ABCA13 TCP11L1 ARHGAP17 PHKA1 UGP2 KYNU	1.55e-06	166	150	7	a2ce44702a0cd5fa5872cac3302d3c451205feef
ToppCell	facs-Lung-Endomucin-3m-Myeloid-myeloid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AP1S3 ABCA13 TCP11L1 ARHGAP17 PHKA1 UGP2 KYNU	1.55e-06	166	150	7	0f641302a6b71c4badaaf20f51162bfc2386b167
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP10 DTNA SYNE1 CSMD2 ADCY1 SLIT3 DMD	3.29e-06	186	150	7	4780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP10 DTNA CSMD2 ADCY1 THBS2 SLIT3 DMD	3.29e-06	186	150	7	a95744b8649096bd7cfc3591a02841fa411085b3
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_ALM_Olfr111_Nxph1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SCN11A GRB7 THBS2 NBEAL2 KCNJ5 KYNU	3.65e-06	122	150	6	dba1c647172a11381efcb178a23808161908daa3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EPS8 ARHGAP10 LAMA2 ARHGAP17 AGTR1 SLIT3 DMD	3.92e-06	191	150	7	7b0d42a877540dbb346a76a62403e0d5d3e07fa6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EPS8 ARHGAP10 LAMA2 ARHGAP17 AGTR1 SLIT3 DMD	3.92e-06	191	150	7	cd854b9c426924fdc84bf7f411f6dea447143e79
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EPS8 ARHGAP10 LAMA2 CHST15 AGTR1 SLIT3 DMD	4.20e-06	193	150	7	c8c21eee8c6c086dc2faf416669cd4a002870fbe
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EPS8 ARHGAP10 LAMA2 CHST15 AGTR1 SLIT3 DMD	4.20e-06	193	150	7	5b602b1702283184bd3943c2a6f2290b7c37e407
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ABCA13 PPFIA4 NFKBIZ EVPL CSMD2 ADCY1 DNAH14	4.50e-06	195	150	7	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ABCA13 PPFIA4 NFKBIZ EVPL CSMD2 ADCY1 DNAH14	4.50e-06	195	150	7	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_ALM_Olfr111_Spon1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TEX13C GRB7 GADD45A KCNJ5 KYNU PMFBP1	4.61e-06	127	150	6	cd69ba386796715e87674f8324d2acaad1d4d094
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6b\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GRB7 GADD45A MMRN1 THBS2 KCNJ5 KYNU	8.07e-06	140	150	6	17005ca714ba03d7528fe7979ffb4654a46b666c
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	DTNA LYST PTPRC CD101 JAKMIP1 PDCD1LG2	1.55e-05	157	150	6	f2bc60ec0305b056d79f1b7fd6b5e3730d606916
ToppCell	Adult-Mesenchymal-myofibroblast_cell-D175\|Adult / Lineage, Cell type, age group and donor	LAMA2 CSMD2 FSIP2 THBS2 STAG3 CCDC158	1.79e-05	161	150	6	048b7dc00746987a24bf870d4d278c4183eb04a2
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	CHERP INTS3 TRAK1 SMG7 USP40 C19orf44	2.12e-05	166	150	6	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-double_negative_T_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUP98 NFKBIZ STAT5A MAPRE3 SMG7 GOLGA1	2.27e-05	168	150	6	de1042267407719f19eb3f580a5df0c9cd0e8273
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8\|TCGA-Thryoid / Sample_Type by Project: Shred V9	LCA5 EPS8 PTPRG SYT11 SLIT3 DMD	2.27e-05	168	150	6	00646601548b0fee42ae16bfa5e93603bc7c5129
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DTNA CSMD2 THBS2 SLIT3 DMD PMFBP1	2.51e-05	171	150	6	4ede831aed364cb5271f49a8b09bb6d0452f9b35
ToppCell	390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	LRRC24 AP1S3 DYNC2H1 NUP98 CD101 SLIT3	2.68e-05	173	150	6	b9dee61973559e8c2fef3f2dafd43475b386befb
ToppCell	PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARHGAP10 CDH23 GADD45A MMRN1 NBEAL2 KCNJ5	3.15e-05	178	150	6	9e1f2596fcea5b79cc50b58d83706bb8605e224f
ToppCell	PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARHGAP10 CDH23 GADD45A MMRN1 NBEAL2 KCNJ5	3.15e-05	178	150	6	aa659bd283c4dfbe292cd8698bbf6b1999ca3314
ToppCell	PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARHGAP10 CDH23 GADD45A MMRN1 NBEAL2 KCNJ5	3.15e-05	178	150	6	bf1d273802a4f42e52ea1bd2a0cae2039559c093
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2\|TCGA-Skin / Sample_Type by Project: Shred V9	NPC1 AP1S3 CAPN2 LYST HEATR6 PPIP5K1	3.45e-05	181	150	6	9d5b331cabc5524f0a9fd8b571e87be4c447c7d4
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-Lymphoid_DC\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SCN11A ARHGAP10 GADD45A GPC5 KYNU PDCD1LG2	3.67e-05	183	150	6	9ca4954faaba50466c35121d6765895e955178aa
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EPS8 ARHGAP10 LAMA2 AGTR1 SLIT3 DMD	3.67e-05	183	150	6	667717366cb181b8a04a347e64f0f5a4dfc6ee7f
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPS8 LAMA2 AGTR1 PLCB1 GPC5 DMD	3.79e-05	184	150	6	689a8af81a79a4bb3123cfa01958c953eab5de98
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPS8 LAMA2 AGTR1 PLCB1 GPC5 DMD	3.79e-05	184	150	6	327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b
ToppCell	COVID-19-Fibroblasts-Pericytes\|COVID-19 / group, cell type (main and fine annotations)	EPS8 ARHGAP10 PTPRG AGTR1 SLIT3 PLCB1	3.90e-05	185	150	6	4905adaeeffd353e089578e5ea614437dbe794e6
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	NPC1 KNTC1 HEATR1 ANKRD36C PTPRC NUP155	4.02e-05	186	150	6	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	EPS8 ABCA13 NFKBIZ DNAH14 PTPRG GPC5	4.02e-05	186	150	6	acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	DTNA LAMA2 THBS2 PTPRG SLIT3 DMD	4.14e-05	187	150	6	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	COVID-19-kidney-Fibroblast-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	EPS8 THBS2 CHST15 AGTR1 SLIT3 DMD	4.14e-05	187	150	6	76bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	RICTOR ANKRD36C TASOR2 RLF PTPRC PLCB1	4.27e-05	188	150	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	Control-Myeloid-Monocytes\|Control / group, cell type (main and fine annotations)	CDH23 LYST PTPRC CHST15 PLCB1 KYNU	4.40e-05	189	150	6	3335d16bd0ffa0c1ddd06d7da645299148130c3f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 DTNA LAMA2 SLITRK3 THBS2 DMD	4.53e-05	190	150	6	2e88e366d377d74deb53a4ea870973ce5c6532e8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 DTNA LAMA2 SLITRK3 THBS2 DMD	4.53e-05	190	150	6	0028f886c789ba238c031eae5d96acaed4af8c25
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DTNA CSMD2 ADCY1 THBS2 SLIT3 DMD	4.53e-05	190	150	6	73d94fbae92029745989a8712eed8b99fd84c193
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	KNTC1 HEATR1 ANKRD36C LYST PTPRC NUP155	4.66e-05	191	150	6	9454f642c3621370fa23640b631301346b300950
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	EPS8 DYNC2H1 LAMA2 NFKBIZ SLC25A13 PLCB1	4.66e-05	191	150	6	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SUPT3H SLF1 SYNE1 ACTN4 LYST CD101	5.08e-05	194	150	6	b0a7f5ca0c6f4f5764a8b35b5de80d82b828c66c
ToppCell	COVID-19-lung-Pericytes/_Smooth_Muscle\|lung / Disease (COVID-19 only), tissue and cell type	EPS8 ARHGAP10 AGTR1 SLIT3 PLCB1 DMD	5.08e-05	194	150	6	5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LAMA2 THBS2 PTPRG SLIT3 PLCB1 DNMT1	5.23e-05	195	150	6	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	CV-Severe-6\|CV / Virus stimulation, Condition and Cluster	OAS2 NFKBIZ GTF3C1 SYT11 UGP2 JAKMIP1	5.23e-05	195	150	6	69095c6ce2a7e763afa543c10d5710e0c3dda769
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 LAMA2 CHST15 AGTR1 SLIT3 DMD	5.23e-05	195	150	6	cad6563cc51d212554152c727fc2c249c6a07e4d
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	EPS8 DYNC2H1 LAMA2 NFKBIZ PTPRG PLCB1	5.23e-05	195	150	6	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 LAMA2 CHST15 AGTR1 SLIT3 DMD	5.23e-05	195	150	6	783bfa8110161cbd6def50ce849cae676c39c458
ToppCell	COVID-19_Severe-Lymphoid_T/NK-gd_T\|COVID-19_Severe / Disease group, lineage and cell class	SYNE1 LAMA2 PTPRC GTF3C1 SYT11 JAKMIP1	5.23e-05	195	150	6	9990440bda7fac5d00ef80444fab07459be625e1
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 DTNA LAMA2 THBS2 SLIT3 DMD	5.38e-05	196	150	6	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	SYNE1 LAMA2 PTPRC GTF3C1 SYT11 JAKMIP1	5.38e-05	196	150	6	418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SYNE1 LAMA2 PTPRC GTF3C1 SYT11 JAKMIP1	5.38e-05	196	150	6	581fc8c8d42005aacd7b401a2c9d1fc331fb4af7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 LAMA2 THBS2 AGTR1 SLIT3 DMD	5.38e-05	196	150	6	3a6c942e2907aa07b5e12dbf9019d18f7bfca507
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 DTNA LAMA2 THBS2 SLIT3 DMD	5.38e-05	196	150	6	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 LAMA2 THBS2 AGTR1 SLIT3 DMD	5.38e-05	196	150	6	bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70
ToppCell	COVID-19-lung-Pericytes/_Smooth_Muscle\|COVID-19 / Disease (COVID-19 only), tissue and cell type	EPS8 ARHGAP10 AGTR1 SLIT3 PLCB1 DMD	5.38e-05	196	150	6	754a3613340932563cd8424d775e18b93c3a1aaa
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SYNE1 LAMA2 PTPRC GTF3C1 SYT11 JAKMIP1	5.38e-05	196	150	6	6beaf0c2799424c59819b286fbb5c1a83d85e4d1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SYNE1 LAMA2 PTPRC GTF3C1 SYT11 JAKMIP1	5.38e-05	196	150	6	c35f2349dfe35baa845f790b9f31673dceac54c0
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rprm\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GRB7 GADD45A MMRN1 KCNJ5 PMFBP1	5.39e-05	120	150	5	2b7596946f9268c4202348adf3069decd8313bb0
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EPS8 ARHGAP10 SYNE1 LAMA2 SLIT3 DMD	5.53e-05	197	150	6	85a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 FSIP1 DYNC2H1 SYNE1 VWA3B DMD	5.53e-05	197	150	6	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA2 THBS2 CHST15 AGTR1 SLIT3 DMD	5.53e-05	197	150	6	ae0435f4b4a9cdedb1c201fc56921048390097bf
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EPS8 ARHGAP10 SYNE1 LAMA2 SLIT3 DMD	5.53e-05	197	150	6	e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA2 THBS2 CHST15 AGTR1 SLIT3 DMD	5.53e-05	197	150	6	37f6b6f2809b952382eaebb642b0aad6371f4251
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EPS8 ARHGAP10 SYNE1 LAMA2 SLIT3 DMD	5.53e-05	197	150	6	9b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EPS8 ARHGAP10 LAMA2 AGTR1 SLIT3 DMD	5.53e-05	197	150	6	80e153790cef37b743e22a7370ff5b3a6abf147d
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	DTNA LAMA2 CSMD2 THBS2 PTPRG SLIT3	5.53e-05	197	150	6	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EPS8 ARHGAP10 LAMA2 AGTR1 SLIT3 DMD	5.69e-05	198	150	6	79576525a10ed3e3a9d1608077cd16ecda23376f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EPS8 ARHGAP10 SYNE1 LAMA2 SLIT3 DMD	5.69e-05	198	150	6	a860246bcea847249a78fd2e86ed8e04371060db
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	EPS8 CEP162 CCDC18 NFKBIZ VPS13D CHST15	5.69e-05	198	150	6	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	Healthy_Control-Myeloid-Macrophages-FCN1+SPP1+\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	CAPN2 NFKBIZ LYST GADD45A KYNU PLSCR1	5.69e-05	198	150	6	aa90326b82e21de37af5642df6a70a8b21af7f04
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	NPC1 SYNE1 RICTOR ANKRD36C SNRNP200 VPS13B	5.85e-05	199	150	6	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LRRC24 APLP1 MAPRE3 SYT11 KCNJ5 JAKMIP1	5.85e-05	199	150	6	b4824d3683a4e3025b8e74a0f1755b331b2a0ba7
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SYNE1 NFKBIZ LYST GADD45A NBEAL2 PLSCR1	5.85e-05	199	150	6	b7af2b4fe6866cc8c78cf0f78390aab1b1b389ba
ToppCell	severe-gd_T\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SYNE1 PTPRC GTF3C1 SYT11 PLCB1 JAKMIP1	5.85e-05	199	150	6	e5a17a9f8f3be05d6abe1116607d17633df3c7ef
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	LAMA2 THBS2 CHST15 AGTR1 SLIT3 DMD	5.85e-05	199	150	6	9503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP10 SYNE1 LAMA2 THBS2 PTPRG GPC5	6.02e-05	200	150	6	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SYNE1 NFKBIZ LYST GADD45A NBEAL2 PLSCR1	6.02e-05	200	150	6	808571d74bb5c4d765ff13fc9393f88020d4e90d
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T\|COVID-19_Severe / Disease, condition lineage and cell class	SYNE1 LAMA2 PTPRC GTF3C1 SYT11 JAKMIP1	6.02e-05	200	150	6	f72bc3f6606ae77fe1b0a972e35b3ce0727804d9
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GRB7 GADD45A KCNJ5 KYNU PMFBP1	1.16e-04	141	150	5	5ef3166c5271aa90fd0633016edfe2c74b835319
ToppCell	Severe-B_intermediate-14\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	DNAH14 STAT5A SLC25A13 CD101 CCDC158	1.20e-04	142	150	5	f9cbc266fcea19bec504be4f3a28d1173c6b2e3c
ToppCell	droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l32\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CUL9 GADD45A MMRN1 STAG3	1.47e-04	79	150	4	11e92ae55dae24b6f73dd5a52e1c3c4e579ddf7b
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SUPT3H PSKH1 HEATR1 JAKMIP1 TXLNG	1.50e-04	149	150	5	1328ce0104d40215ee68abfdbf74eb47b87a7b5b
ToppCell	tumor_Lymph_Node_/_Brain-B_lymphocytes-Undetermined\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	CUL9 GBA2 ZBTB24 C19orf44 TXLNG	1.75e-04	154	150	5	e16f200391537aa1002b0079481b94e1fb86b9ad
ToppCell	368C-Endothelial_cells-Endothelial-E\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	EMC1 PPFIA4 FSIP2 COMMD2 SLIT3	1.86e-04	156	150	5	4877aabf647238c0279e497345b6a6d5ee07ef9c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 LAMA2 APLP1 THBS2 DMD	1.86e-04	156	150	5	d5207dbfbcfb885557ea1378dfe6a56d7102e94a
ToppCell	368C-Endothelial_cells-Endothelial-E-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	EMC1 PPFIA4 FSIP2 COMMD2 SLIT3	1.86e-04	156	150	5	1d681fa17e62815f5d5f90c86be3c248b38e011b
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_D2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	SUPT3H POLR2E OAS2 SLC46A1 USP40	1.86e-04	156	150	5	0b3630fd4479291599e1674e87eba6f93877ac3a
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP10 LAMA2 APLP1 THBS2 DMD	1.86e-04	156	150	5	363f1b661048d25895e2b8681c82894c957b29c0
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD8-Trm/em_CD8\|GI_large-bowel / Manually curated celltypes from each tissue	CAPN2 CUL9 LYST PLCB1 JAKMIP1	1.91e-04	157	150	5	d85304af4cd3b8aaedc5362a8223537e1b9dbec2
ToppCell	TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic-6\|TCGA-Mesothelium / Sample_Type by Project: Shred V9	ARHGAP10 TCP11L1 EXOC5 DNMT1 PDCD1LG2	2.03e-04	159	150	5	85501c636cd04f15ba1be24df1ba7ac909633ce8
ToppCell	droplet-Lung-immune-endo-depleted-3m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMG5 TEX10 THBS2 C19orf44 JAKMIP1	2.03e-04	159	150	5	74655c22e9fdd88e3052b9dfb954c8fb678bd2d8
ToppCell	droplet-Liver-Hepatocytes-24m-Lymphocytic\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDH23 ELOVL7 SYT11 CCDC158 PDCD1LG2	2.27e-04	163	150	5	924c666596bbb42d7876c9b164a725277f3efa5f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SYNE1 LAMA2 PTPRG TAF7L AGTR1	2.41e-04	165	150	5	e2aebb2fe197151e019371b8960f76f0c2386f08
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SYNE1 LAMA2 PTPRG TAF7L AGTR1	2.41e-04	165	150	5	b087771499aeb31cc4a338d2d0a9392a4ec1ac45
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SYNE1 LAMA2 PTPRG TAF7L AGTR1	2.41e-04	165	150	5	d8f8b088fd28a6b9dbd6b51bcaee42000e963321
ToppCell	Bronchial_Biopsy-Immune-T_and_NK\|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X	SUPT3H LAMA2 ELOVL7 MMRN1 FSIP2	2.62e-04	168	150	5	435b2f238fbb3f50427e8cdecf2220615015153c
ToppCell	droplet-Liver-HEPATOCYTES-1m-Lymphocytic\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DHX16 AP1S3 NUP98 JAKMIP1 PDCD1LG2	2.69e-04	169	150	5	d721dbb317a88113b4f76688111908d00f23e899
Drug	Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; MCF7; HT_HG-U133A	DNAH3 EMC1 ARHGAP10 DTNA CUL9 OAS2 SMG5 GOSR2 LYST PLCB1	6.17e-07	195	148	10	1527_DN
Drug	Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; MCF7; HT_HG-U133A	EMC1 DTNA GRB7 NDUFA5 LYST VPS13D SMG7 FASTK PLCB1 VPS13B	6.77e-07	197	148	10	5436_DN
Drug	(-)-MK 801 hydrogen maleate [77086-19-2]; Down 200; 11.8uM; HL60; HT_HG-U133A	ARHGAP10 CEP162 CYTH1 LAMA2 OAS2 FASTK PLCB1 TXLNG VPS13B PMFBP1	7.09e-07	198	148	10	3081_DN
Drug	Dihydrostreptomycin sulfate [5490-27-7]; Up 200; 2.8uM; HL60; HG-U133A	CHERP DYNC2H1 TCP11L1 GRB7 SMG5 STAT5A VPS13D SYT11 STAG3 GOLGA1	7.09e-07	198	148	10	1391_UP
Drug	Cyclosporin A [59865-13-3]; Down 200; 3.4uM; PC3; HT_HG-U133A	DNAH3 CEP162 SYNE1 CYTH1 CUL9 ADCY1 MAPRE3 SLC9A2 KYNU	5.65e-06	196	148	9	4586_DN
Drug	Nizatidine [76963-41-2]; Up 200; 12uM; PC3; HT_HG-U133A	DTNA CEP162 CUL9 VPS13D SLC9A2 NBEAL2 CD101 DMD STAG3	5.65e-06	196	148	9	6305_UP
Drug	fludrocortisone acetate; Up 200; 1uM; MCF7; HG-U133A	TCP11L1 ACTN4 GOSR2 GADD45A TRAK1 VPS13D SMG7 NBEAL2 SLIT3	5.89e-06	197	148	9	281_UP
Drug	LY 294002; Up 200; 0.1uM; HL60; HT_HG-U133A	DTNA TCP11L1 CAPN2 LYST STAT5B EXOC5 FASTK PLCB1 VPS13B	6.14e-06	198	148	9	1157_UP
Drug	Sulfisoxazole [127-69-5]; Down 200; 15uM; PC3; HT_HG-U133A	DTNA OAS2 PPARA NDUFA5 VPS13D SMG7 SYT11 NBEAL2 CD101	6.14e-06	198	148	9	4661_DN
Drug	Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; HL60; HT_HG-U133A	DYNC2H1 DTNA LAMA2 SMG5 NEK9 VPS13D SMG7 GTF3C1 PMFBP1	6.39e-06	199	148	9	3079_DN
Drug	tribromoethanol	CDH23 LYST NR1I2 AGTR1	1.38e-05	23	148	4	CID000006400
Drug	C75; Down 200; 10uM; PC3; HT_HG-U133A	CEP162 CYTH1 LAMA2 GRB7 CUL9 OAS2 APLP1 KYNU	3.67e-05	191	148	8	6399_DN
Drug	Amrinone [60719-84-8]; Down 200; 21.4uM; PC3; HT_HG-U133A	DNAH3 EMC1 DTNA SYNE1 GRB7 OAS2 APLP1 CD101	3.95e-05	193	148	8	4488_DN
Drug	Acyclovir [59277-89-3]; Down 200; 17.8uM; MCF7; HT_HG-U133A	SYNE1 TCP11L1 CYTH1 GRB7 TRAK1 MAPRE3 VPS13D KYNU	4.10e-05	194	148	8	5278_DN
Drug	Fluorometholone [426-13-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A	DNAH3 DTNA CEP162 OAS2 SMG5 GADD45A TRAK1 VPS13D	4.25e-05	195	148	8	6247_UP
Drug	Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; HL60; HT_HG-U133A	SUPT3H DTNA OAS2 SMG5 GOSR2 GTF3C1 PLSCR3 PMFBP1	4.25e-05	195	148	8	1273_UP
Drug	Antipyrine, 4-hydroxy [1672-63-5]; Up 200; 19.6uM; MCF7; HT_HG-U133A	SCN11A CYTH1 CUL9 APLP1 GOSR2 NEK9 TRAK1 VPS13D	4.40e-05	196	148	8	1497_UP
Drug	Apramycin [37321-09-8]; Down 200; 7.4uM; HL60; HT_HG-U133A	NRBP1 DYNC2H1 GOSR2 SMG7 GTF3C1 PLSCR3 PLSCR1 GOLGA1	4.40e-05	196	148	8	2914_DN
Drug	copper(II) sulfate pentahydrate; Up 200; 100uM; MCF7; HG-U133A	NRDC CUL9 TFIP11 SMG5 GOSR2 GADD45A FASTK SLIT3	4.57e-05	197	148	8	438_UP
Drug	sodium 4-phenylbutyrate; Down 200; 1000uM; MCF7; HG-U133A	EMC1 CHERP CAPN2 CUL9 STAT5A VPS13D FASTK STAG3	4.73e-05	198	148	8	407_DN
Drug	Ampicillin trihydrate [7177-48-2]; Down 200; 10uM; MCF7; HT_HG-U133A	SCN11A ARHGAP10 CYTH1 OAS2 NDUFA5 LYST TRAK1 FASTK	4.73e-05	198	148	8	1530_DN
Drug	Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; HL60; HT_HG-U133A	DTNA PSKH1 SMG5 GOSR2 LYST TRAK1 HEATR6 GOLGA1	4.73e-05	198	148	8	1340_DN
Drug	Dibucaine [85-79-0]; Down 200; 11.6uM; HL60; HG-U133A	TMPRSS15 DTNA PSKH1 GOSR2 TRAK1 SMG7 FASTK SLC25A13	4.73e-05	198	148	8	1969_DN
Drug	Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A	TCP11L1 CUL9 SLITRK3 LYST STAT5B TRAK1 VPS13D KCNJ5	4.73e-05	198	148	8	3223_UP
Drug	GBR 12909 dihydrochloride [67469-78-7]; Down 200; 7.6uM; PC3; HT_HG-U133A	DNAH3 PPARA NDUFA5 GOSR2 NEK9 TRAK1 VPS13D SMG7	4.90e-05	199	148	8	4641_DN
Drug	Nitrofurantoin [67-20-9]; Up 200; 16.8uM; PC3; HT_HG-U133A	SCN11A CYTH1 CUL9 MAPRE3 SLIT3 PLCB1 SNRNP200 STAG3	4.90e-05	199	148	8	3674_UP
Drug	Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; MCF7; HT_HG-U133A	CEP162 PSKH1 GRB7 OAS2 APLP1 LYST TRAK1 PLCB1	4.90e-05	199	148	8	3266_DN
Drug	Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; HL60; HT_HG-U133A	EMC1 DTNA SYNE1 TCP11L1 CAPN2 LAMA2 TFIP11 FASTK	5.08e-05	200	148	8	3078_DN
Drug	Clorgyline	DYNC2H1 CDH23 RICTOR SHOC2 NR1I2 CEP135 NUDCD1	1.17e-04	168	148	7	ctd:D003010
Drug	menthol glucuronide	APOB UGP2	1.25e-04	3	148	2	CID000133208
Drug	QM96639	KNTC1 GTF2H5	1.25e-04	3	148	2	CID000471980
Drug	QM96521	KNTC1 GTF2H5	1.25e-04	3	148	2	CID000471978
Drug	indoxyl-beta-D-glucoside	GBA2 SLC5A4 UGP2	1.71e-04	17	148	3	CID000092769
Drug	Sparteine (-) [90-39-1]; Down 200; 17uM; MCF7; HT_HG-U133A	EMC1 EVPL GOSR2 VPS13D SMG7 NBEAL2 VPS13B	2.43e-04	189	148	7	2790_DN
Drug	AZD 1480	STAT5A STAT5B	2.50e-04	4	148	2	ctd:C545606
Drug	perfluoroundecanoic acid	PPARA LYST	2.50e-04	4	148	2	CID000077221
Drug	4'-O-(beta-D-glucopyranosyl)-D-pantothenic acid	GBA2 UGP2	2.50e-04	4	148	2	CID003082306
Drug	Propantheline bromide [50-34-0]; Down 200; 9uM; MCF7; HT_HG-U133A	DTNA TCP11L1 POLR2E ACTN4 GOSR2 EXOC5 SMG7	2.51e-04	190	148	7	3352_DN
Drug	5253409; Up 200; 17uM; MCF7; HT_HG-U133A_EA	SCN11A SUPT3H TCP11L1 SMG5 GADD45A SLC9A2 STAG3	2.51e-04	190	148	7	961_UP
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	SUPT3H DTNA GRB7 APLP1 NEK9 TRAK1 PLCB1	2.51e-04	190	148	7	6956_UP
Drug	Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; MCF7; HT_HG-U133A	DYNC2H1 DTNA CUL9 LYST NEK9 TRAK1 MAPRE3	2.59e-04	191	148	7	7417_UP
Drug	Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A	CCP110 GOSR2 NEK9 ADCY1 VPS13D PLCB1 VPS13B	2.59e-04	191	148	7	4168_DN
Drug	Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A	CEP162 TCP11L1 STAT5A NBEAL2 CEP135 KYNU PMFBP1	2.76e-04	193	148	7	1148_UP
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA	DTNA NUP98 GADD45A STAT5B TRAK1 VPS13D STAG3	2.84e-04	194	148	7	1060_UP
Drug	Viomycin sulfate [37883-00-4]; Down 200; 5.2uM; MCF7; HT_HG-U133A	GOSR2 LYST ADCY1 STAT5B SLC9A2 NBEAL2 PLSCR3	2.84e-04	194	148	7	7036_DN
Drug	(S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; MCF7; HT_HG-U133A	EMC1 DTNA ARHGAP17 TFIP11 TRAK1 VPS13D PLCB1	2.93e-04	195	148	7	5325_UP
Drug	Bupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; MCF7; HT_HG-U133A	DTNA CEP162 PSKH1 CYTH1 TFIP11 MAPRE3 PLCB1	2.93e-04	195	148	7	7435_UP
Drug	Reserpine [50-55-5]; Up 200; 6.6uM; PC3; HT_HG-U133A	DTNA LAMA2 GRB7 CUL9 MAPRE3 KCNJ5 AGTR1	2.93e-04	195	148	7	4203_UP
Drug	monastrol; Up 200; 100uM; MCF7; HG-U133A	CHERP CEP162 CYTH1 SMG5 STAT5A VPS13D SLIT3	2.93e-04	195	148	7	596_UP
Drug	S(+)-Terguride [37686-84-3]; Up 200; 11.8uM; PC3; HT_HG-U133A	DTNA TCP11L1 OAS2 SMG5 VPS13D KYNU PMFBP1	2.93e-04	195	148	7	6299_UP
Drug	Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; PC3; HT_HG-U133A	EMC1 ARHGAP10 OAS2 EVPL SMG7 TXLNG GOLGA1	2.93e-04	195	148	7	4644_DN
Drug	Metaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; MCF7; HT_HG-U133A	DTNA PPARA GOSR2 MAPRE3 VPS13D SMG7 PLSCR3	2.93e-04	195	148	7	4692_DN
Drug	Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A	DYNC2H1 DTNA GOSR2 STAT5B TRAK1 NBEAL2 GOLGA1	2.93e-04	195	148	7	3409_DN
Drug	Sulfapyridine [144-83-2]; Down 200; 16uM; MCF7; HT_HG-U133A	SUPT3H EMC1 DTNA CEP162 VPS13D PLCB1 VPS13B	2.93e-04	195	148	7	6101_DN
Drug	5213008; Down 200; 18uM; MCF7; HT_HG-U133A_EA	CEP162 PSKH1 TCP11L1 CYTH1 APLP1 TRAK1 PLSCR3	2.93e-04	195	148	7	898_DN
Drug	Erythromycin [114-07-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A	SUPT3H CYTH1 APLP1 LYST VPS13D PLSCR3 GOLGA1	2.93e-04	195	148	7	5329_UP
Drug	2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A	EMC1 SMG5 ADCY1 SLC9A2 SMG7 CEP135 PLSCR3	2.93e-04	195	148	7	1639_DN
Drug	Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; MCF7; HT_HG-U133A	DNAH3 GRB7 TRAK1 VPS13D GTF3C1 PLSCR3 STAG3	3.03e-04	196	148	7	3248_DN
Drug	Cefsulodin sodium salt [52152-93-9]; Down 200; 7.2uM; MCF7; HT_HG-U133A	SUPT3H TMPRSS15 DTNA TCP11L1 GOSR2 NBEAL2 PLCB1	3.03e-04	196	148	7	4148_DN
Drug	Nimesulide [51803-78-2]; Down 200; 13uM; MCF7; HT_HG-U133A	DTNA NUP98 STAT5B VPS13D SLC9A2 PLSCR3 STAG3	3.03e-04	196	148	7	7024_DN
Drug	Dimethadione [695-53-4]; Down 200; 31uM; HL60; HT_HG-U133A	SCN11A SMG5 VPS13D SMG7 PLCB1 STAG3 PMFBP1	3.03e-04	196	148	7	3029_DN
Drug	Zomepirac sodium salt [64092-48-4]; Up 200; 12.8uM; PC3; HT_HG-U133A	TMPRSS15 DTNA NEK9 MAPRE3 SLC9A2 PTPRC SYT11	3.03e-04	196	148	7	4479_UP
Drug	Midecamycin [35457-80-8]; Up 200; 5uM; MCF7; HT_HG-U133A	SUPT3H DTNA TCP11L1 CYTH1 OAS2 SLC9A2 PLCB1	3.03e-04	196	148	7	5345_UP
Drug	Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A	EMC1 ARHGAP10 CUL9 SMG5 VPS13D PLCB1 VPS13B	3.03e-04	196	148	7	5438_DN
Drug	Gemfibrozil [25812-30-0]; Up 200; 16uM; MCF7; HT_HG-U133A	CUL9 NDUFA5 VPS13D SLC9A2 NR1I2 KCNJ5 VPS13B	3.03e-04	196	148	7	2277_UP
Drug	Cotinine (-) [486-56-6]; Up 200; 22.6uM; PC3; HG-U133A	TMPRSS15 DTNA APLP1 HEATR6 SMG7 GTF3C1 PLSCR3	3.03e-04	196	148	7	1929_UP
Drug	0173570-0000 [211245-44-2]; Down 200; 1uM; PC3; HT_HG-U133A	DNAH3 DTNA EVPL TRAK1 HEATR6 PLSCR3 STAG3	3.03e-04	196	148	7	7391_DN
Drug	Flurbiprofen [5104-49-4]; Down 200; 16.4uM; HL60; HT_HG-U133A	EMC1 CEP162 SYNE1 TCP11L1 SMG7 VPS13B PMFBP1	3.03e-04	196	148	7	3095_DN
Drug	Nadolol [42200-33-9]; Down 200; 13uM; MCF7; HT_HG-U133A	SYNE1 CYTH1 CUL9 EVPL VPS13D KCNJ5 PLSCR3	3.03e-04	196	148	7	3359_DN
Drug	Imipramine hydrochloride [113-52-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A	DYNC2H1 ARHGAP10 CEP162 CYTH1 ACTN4 ADCY1 VPS13D	3.03e-04	196	148	7	1685_DN
Drug	Carisoprodol [78-44-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A	CEP162 PSKH1 GRB7 APLP1 LYST TRAK1 FASTK	3.03e-04	196	148	7	3251_DN
Drug	Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; PC3; HT_HG-U133A	CEP162 SYNE1 TCP11L1 GOSR2 TRAK1 MAPRE3 SLC9A2	3.03e-04	196	148	7	4590_DN
Drug	Methoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; MCF7; HT_HG-U133A	EMC1 DTNA CEP162 TCP11L1 CYTH1 SMG7 PLCB1	3.12e-04	197	148	7	2848_DN
Drug	Naltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A	TMPRSS15 CEP162 TRAK1 VPS13D FASTK CEP135 PLSCR3	3.12e-04	197	148	7	6241_UP
Drug	Cyclacillin [3485-14-1]; Down 200; 11.8uM; PC3; HT_HG-U133A	SCN11A DTNA SYNE1 LAMA2 PPARA GOSR2 MAPRE3	3.12e-04	197	148	7	3800_DN
Drug	Bromopride [4093-35-0]; Up 200; 11.6uM; PC3; HT_HG-U133A	SCN11A SUPT3H MAPRE3 SYT11 TAF7L DMD PMFBP1	3.12e-04	197	148	7	3719_UP
Drug	LY294002; Down 200; 10uM; PC3; HG-U133A	EMC1 TCP11L1 EVPL STAT5A SLIT3 PLCB1 GOLGA1	3.12e-04	197	148	7	429_DN
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Up 200; 11.2uM; HL60; HT_HG-U133A	DYNC2H1 CEP162 TRAK1 SMG7 TXLNG GOLGA1 PMFBP1	3.12e-04	197	148	7	1848_UP
Drug	Benzthiazide [91-33-8]; Down 200; 9.2uM; PC3; HT_HG-U133A	DTNA CAPN2 NUP98 PPARA TRAK1 SLC9A2 STAG3	3.12e-04	197	148	7	6607_DN
Drug	Trolox [53188-07-1]; Up 200; 16uM; PC3; HT_HG-U133A	CCP110 CEP162 TRAK1 SLC9A2 SMG7 NBEAL2 STAG3	3.12e-04	197	148	7	7304_UP
Drug	Vitamin K2 [11032-49-8]; Down 200; 9uM; PC3; HT_HG-U133A	SCN11A DTNA CAPN2 GRB7 NEK9 MAPRE3 KYNU	3.12e-04	197	148	7	3798_DN
Drug	Halofantrine hydrochloride [36167-63-2]; Down 200; 7.4uM; MCF7; HT_HG-U133A	APLP1 SMG5 GOSR2 STAT5B TRAK1 PLSCR3 KYNU	3.12e-04	197	148	7	6509_DN
Drug	Skimmianine [83-95-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	DNAH3 TMPRSS15 PSKH1 APLP1 TRAK1 VPS13D GOLGA1	3.12e-04	197	148	7	5766_DN
Drug	Indoprofen [31842-01-0]; Down 200; 14.2uM; MCF7; HT_HG-U133A	SUPT3H DTNA GRB7 PPARA GOSR2 ADCY1 PLSCR1	3.12e-04	197	148	7	4832_DN
Drug	Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; PC3; HT_HG-U133A	DTNA PPFIA4 CYTH1 MAPRE3 SLC9A2 CD101 KYNU	3.12e-04	197	148	7	4673_DN
Drug	Gliclazide [21187-98-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A	TFIP11 GOSR2 TRAK1 VPS13D SMG7 TXLNG STAG3	3.12e-04	197	148	7	5514_DN
Drug	alpha-estradiol; Up 200; 0.01uM; PC3; HT_HG-U133A	TCP11L1 CAPN2 OAS2 EVPL SMG5 PLSCR3 KYNU	3.12e-04	197	148	7	1210_UP
Drug	Norfloxacin [70458-96-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A	EMC1 CEP162 TCP11L1 SMG5 GOSR2 NEK9 TRAK1	3.12e-04	197	148	7	2253_DN
Drug	Acenocoumarol [152-72-7]; Up 200; 11.4uM; HL60; HG-U133A	EMC1 GRB7 TFIP11 SMG5 GTF3C1 FASTK NBEAL2	3.12e-04	197	148	7	1394_UP
Drug	Spironolactone [52-01-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A	TMPRSS15 EMC1 DTNA CEP162 NDUFA5 STAT5B TRAK1	3.12e-04	197	148	7	6255_UP
Drug	Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; PC3; HG-U133A	TMPRSS15 NRDC EVPL GOSR2 PHKA1 FASTK PLSCR3	3.12e-04	197	148	7	1898_DN
Drug	MEHP	PPARA STAT5A STAT5B NR1I2	3.13e-04	50	148	4	CID000020393
Drug	3-Acetamidocoumarin [779-30-6]; Up 200; 19.6uM; PC3; HT_HG-U133A	DTNA CYTH1 NEK9 SMG7 CEP135 TTC21B PMFBP1	3.22e-04	198	148	7	4601_UP
Drug	Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; HL60; HT_HG-U133A	SUPT3H EMC1 ZBTB24 TRAK1 VPS13D FASTK TXLNG	3.22e-04	198	148	7	2560_DN
Drug	Netilmicin sulfate [56931-57-2]; Up 200; 2.8uM; PC3; HT_HG-U133A	EVPL MAPRE3 NBEAL2 CD101 PLSCR3 TXLNG SNRNP200	3.22e-04	198	148	7	7302_UP
Drug	Tocopherol (R,S) [10191-41-0]; Down 200; 9.2uM; HL60; HT_HG-U133A	PSKH1 SMG5 GOSR2 TRAK1 SMG7 TXLNG PLSCR1	3.22e-04	198	148	7	1320_DN
Drug	Vincamine [1617-90-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A	SCN11A SUPT3H APLP1 MAPRE3 VPS13D KCNJ5 PMFBP1	3.22e-04	198	148	7	3865_UP
Drug	fluphenazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A	DNAH3 CUL9 SMG5 NEK9 ADCY1 TXLNG STAG3	3.22e-04	198	148	7	1237_DN
Drug	Flufenamic acid [530-78-9]; Up 200; 14.2uM; HL60; HG-U133A	CHERP SMG5 LYST STAT5B VPS13D SLIT3 GOLGA1	3.22e-04	198	148	7	1420_UP
Drug	Harmane hydrochloride [21655-84-5]; Down 200; 18.2uM; PC3; HT_HG-U133A	SYNE1 TCP11L1 NDUFA5 MAPRE3 SMG7 PLCB1 KYNU	3.22e-04	198	148	7	4584_DN
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	EPS8 CDH23 ADCY1	3.14e-05	13	144	3	C1846647
Disease	Paroxysmal atrial fibrillation	ARHGAP10 PPFIA4 CYTH1 GOSR2 KCNJ5 SLIT3	1.21e-04	156	144	6	C0235480
Disease	familial atrial fibrillation	ARHGAP10 PPFIA4 CYTH1 GOSR2 KCNJ5 SLIT3	1.21e-04	156	144	6	C3468561
Disease	Persistent atrial fibrillation	ARHGAP10 PPFIA4 CYTH1 GOSR2 KCNJ5 SLIT3	1.21e-04	156	144	6	C2585653
Disease	Atrial Fibrillation	ARHGAP10 PPFIA4 CYTH1 GOSR2 KCNJ5 SLIT3	1.39e-04	160	144	6	C0004238
Disease	Jeune thoracic dystrophy	DYNC2H1 TTC21B	1.41e-04	4	144	2	cv:C0265275
Disease	Ciliopathies	LCA5 DYNC2H1 CDH23 GLIS2 TTC21B	2.09e-04	110	144	5	C4277690
Disease	Hereditary Sensory Autonomic Neuropathy, Type 5	SCN11A DNMT1	4.89e-04	7	144	2	C0020075
Disease	social communication impairment	SCN11A TTC21B PLCB1	5.09e-04	32	144	3	EFO_0005427
Disease	female fertility, fertility measurement	SUPT3H SYNE1 PDCD1LG2	5.58e-04	33	144	3	EFO_0006918, EFO_0006923
Disease	Muscular Dystrophy	LAMA2 DMD	6.50e-04	8	144	2	C0026850
Disease	Duchenne muscular dystrophy (implicated_via_orthology)	DTNA CAPN2 DMD	7.22e-04	36	144	3	DOID:11723 (implicated_via_orthology)
Disease	Kidney Diseases	PPARA GLIS2 AGTR1 TTC21B	9.23e-04	88	144	4	C0022658
Disease	urate measurement, bone density	SYNE1 DNAH14 FSIP2 HEATR6 PTPRG GLIS2 USP40 PLCB1 VWA3B GPC5	9.55e-04	619	144	10	EFO_0003923, EFO_0004531
Disease	Jeune thoracic dystrophy	DYNC2H1 TTC21B	1.26e-03	11	144	2	C0265275
Disease	coronary artery disease (is_implicated_in)	APOB PPARA ARHGAP31 AGTR1	1.48e-03	100	144	4	DOID:3393 (is_implicated_in)
Disease	Gastrointestinal Stromal Sarcoma	NPC1 GLIS2 DMD	1.58e-03	47	144	3	C3179349
Disease	Short Rib-Polydactyly Syndrome	DYNC2H1 TTC21B	1.78e-03	13	144	2	C0036996
Disease	Nephronophthisis	GLIS2 TTC21B	1.78e-03	13	144	2	C0687120
Disease	gallbladder cancer (is_implicated_in)	RICTOR APOB	1.78e-03	13	144	2	DOID:3121 (is_implicated_in)
Disease	Gastrointestinal Stromal Tumors	NPC1 GLIS2 DMD	1.89e-03	50	144	3	C0238198
Disease	severe combined immunodeficiency (is_implicated_in)	PTPRC RFXANK	2.07e-03	14	144	2	DOID:627 (is_implicated_in)
Disease	Saldino-Noonan Syndrome	DYNC2H1 TTC21B	2.07e-03	14	144	2	C0036069
Disease	Majewski Syndrome	DYNC2H1 TTC21B	2.07e-03	14	144	2	C0024507
Disease	cancer biomarker measurement	FAM135B PPIP5K1	2.38e-03	15	144	2	EFO_0005127
Disease	Hypertriglyceridemia	APOB PPARA	2.38e-03	15	144	2	C0020557
Disease	Carcinoma, Granular Cell	GRB7 STAT5A NR1I2 DNMT1	2.55e-03	116	144	4	C0205644
Disease	Adenocarcinoma, Tubular	GRB7 STAT5A NR1I2 DNMT1	2.55e-03	116	144	4	C0205645
Disease	Adenocarcinoma, Oxyphilic	GRB7 STAT5A NR1I2 DNMT1	2.55e-03	116	144	4	C0205642
Disease	Carcinoma, Cribriform	GRB7 STAT5A NR1I2 DNMT1	2.55e-03	116	144	4	C0205643
Disease	Adenocarcinoma, Basal Cell	GRB7 STAT5A NR1I2 DNMT1	2.55e-03	116	144	4	C0205641
Disease	Adenocarcinoma	GRB7 STAT5A NR1I2 DNMT1	2.55e-03	116	144	4	C0001418
Disease	sleep quality	LAMA2 ADCY1 SLC9A2 NUDCD1	2.71e-03	118	144	4	EFO_0005272
Disease	muscular dystrophy (is_implicated_in)	SYNE1 LAMA2	3.07e-03	17	144	2	DOID:9884 (is_implicated_in)
Disease	Lipidemias	APOB PPARA	3.07e-03	17	144	2	C1706412
Disease	Hyperlipidemia	APOB PPARA	3.07e-03	17	144	2	C0020473
Disease	renovascular hypertension (biomarker_via_orthology)	LAMA2 AGTR1	3.83e-03	19	144	2	DOID:1591 (biomarker_via_orthology)
Disease	anorectal malformation	CSMD2 THBS2	3.83e-03	19	144	2	MONDO_0019938
Disease	alpha-tocopherol measurement	RNF215 GPC5	4.24e-03	20	144	2	EFO_0007898
Disease	body surface area	KNTC1 SUPT3H CYTH1 PPARA ZBTB24 PTPRG GLIS2 SLIT3 DNMT1	4.42e-03	643	144	9	EFO_0022196
Disease	muscular dystrophy (implicated_via_orthology)	LAMA2 DMD	4.67e-03	21	144	2	DOID:9884 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
CLSNEEQIIIHDFIL	PTPRG	1286	P23470
QLQDLVLHFLVLSFD	SYT11	236	Q9BT88
INLLNDVLDTHFSQL	TTC21B	416	Q7Z4L5
RFLQHIEENIINENI	FAM200B	486	P0CF97
ITAEEQHRIQLVFQS	CSMD2	56	Q7Z408
QHRIQLVFQSFALEE	CSMD2	61	Q7Z408
LNLLHEFLQTEIKNQ	DNMT1	46	P26358
HQIFTFLDVLIQLGI	AGTR1	256	P30556
LLEQQHQLIQEALIF	ACTN4	706	O43707
NEHFQSILQTLEEQV	APLP1	351	P51693
AQNLHFVQEVLICLE	ABCA13	456	Q86UQ4
VILLLQHNIDVFSRD	ANKRD36B	201	Q8N2N9
HVSQALLEVEQLLNA	DMD	2006	P11532
EELLAAIANHQVLII	DHX16	406	O60231
RVNFAQTELLIHVVN	CDH23	3001	Q9H251
ELQLHQIAALFTVTV	PDCD1LG2	11	Q9BQ51
AFSLLVHEIQRVQEA	ERAS	191	Q7Z444
LAQLTLEQILEHLDN	INTS3	916	Q68E01
DIQIQFLPDHINIVL	NUDCD1	301	Q96RS6
QAQLHQEEFEVVVIL	KCNJ5	291	P48544
IENQDNELLTLEIVH	AP1S3	71	Q96PC3
DIVILLLQHNIDVFS	ANKRD36C	211	Q5JPF3
LKFQNIVVEILIENH	ARHGAP10	556	A1A4S6
QLLEAIAHFLVVQET	FASTK	256	Q14296
LLILQHIAQNLFIIE	OTOP3	456	Q7RTS5
DFTHLEVLQALEAQL	C19orf81	91	C9J6K1
VNLTNLNLDDIVHIR	NUP98	781	P52948
NNIINHFLCEILAVL	OR13C4	171	Q8NGS5
LQALVSVFVVQLQLH	SLC46A1	126	Q96NT5
INILILEAIENHNLA	MAP3K10	226	Q02779
VAVAANQHLIVQDLV	NFKBIZ	486	Q9BYH8
NSALLQIHQLQAELE	GOLGA1	536	Q92805
QIHQLQAELEALRTL	GOLGA1	541	Q92805
ALNEIVILALLQHDN	NEK9	96	Q8TD19
QLVVHELFSSVLQEI	NUDT22	176	Q9BRQ3
LLNFHLLVNDAVLQA	GPC5	316	P78333
EENLHVLNQTLAEVL	MMRN1	611	Q13201
IHSLDEVNFIQNLVF	PHKA1	156	P46020
DENFDHNTLALILQI	PPFIA4	1066	O75335
QLVTFHIDLNSVDIL	TMPRSS15	151	P98073
RHANIIQLVEVFETQ	PSKH1	151	P11801
IASFIIQEIIENHLQ	FSIP2	4246	Q5CZC0
AISVLHELIQQIFNL	IFNA1;	76	P01562
DQFANLVLHQTVERI	LSM1	36	O15116
DQILIHQQIELLEVL	PLSCR1	106	O15162
LEFLVQIDQILIHQK	PLSCR3	76	Q9NRY6
TLLHLVQQLEQALEE	COMMD2	171	Q86X83
VQHELEAQRSQLLQL	EVPL	931	Q92817
VELHEFTDLNLVQAL	CYTH1	131	Q15438
NRLQVIVDEQHLDFL	HEATR6	106	Q6AI08
LHLQENSIELLEDQA	LRRC24	151	Q50LG9
EISQLIFRHNNEITA	LCA5	156	Q86VQ0
VLQLFIETLLHNTNA	KNTC1	1461	P50748
HIVENEIQASIDQIF	GOSR2	31	O14653
VLAQITELHQNLDGL	LAMA2	2051	P24043
EFLRLQVLEQQHVID	JAKMIP1	396	Q96N16
NQLFELLQDLVDHVN	GLIS2	176	Q9BZE0
VLQHRVVDQLQEQFA	NR1I2	356	O75469
FEDETIRNILLHQLQ	OAS2	271	P29728
EALLINLRDSQVLQH	RICTOR	526	Q6R327
RFTDLLQLVEFHQLN	GRB7	501	Q14451
HQFTIIVAELQKELQ	NUP155	801	O75694
AVFDNLIQLEHLNIV	NRBP1	116	Q9UHY1
DIQILHQVLDLQIAI	NPC1	436	O15118
HQVLDLQIAIENITA	NPC1	441	O15118
NEKLIAHLNIQVDFL	CEP135	266	Q66GS9
QFQIEAHLDTLINEQ	COG6	526	Q9Y2V7
HVLQLAGIEAQQVVL	DYNC2H1	2696	Q8NCM8
RLLEEFVNHIQELQI	EXOC5	41	O00471
IQRHDNVSILFADIV	ADCY1	296	Q08828
NFHNLQEIRQLELVE	ANAPC10	101	Q9UM13
LSSQVEQFLHRNIQE	APOB	4436	P04114
VSQDLFQLHILNVED	CD101	756	Q93033
AHLLVIQNLDELEFI	KLRF2	111	D3W0D1
QHLLALRQEQVTAAV	CHERP	121	Q8IWX8
HLNIISINAFEDDIL	DNAH3	2206	Q8TD57
QHVVRALQTIFELNV	GBA2	776	Q9HCG7
QLVQFVIVAIHISQF	ELOVL7	211	A1L3X0
AHRTSQFQLIQEELL	CCDC18	546	Q5T9S5
HDVLKQQLSLTQQFI	C19orf44	591	Q9H6X5
DRDVALQIHFTLIQA	GADD45A	66	P24522
QEVLIRHFQSQVNEL	CEP162	1256	Q5TB80
EQHAQQLSLLIAEQE	CCP110	661	O43303
QIHISEEQIAIFQVL	DNAH14	796	Q0VDD8
LACDIQQLFIAVTIH	LYST	2496	Q99698
HETDAQILELNQQLV	MAPRE3	196	Q9UPY8
QIHVEQSISLLLNFL	DTNA	101	Q9Y4J8
ELAVTQHQQLAEIDI	FSIP1	311	Q8NA03
NLELHTNALQILLEE	CUL9	2371	Q8IWT3
VNKQLDENISLFLIH	HEATR1	86	Q9H583
ALVQTEDHLLLFLQQ	EMC1	421	Q8N766
QILNHILDDIEFFIT	EPS8	271	Q12929
LLQQHQDRIEQLISE	CCDC158	261	Q5M9N0
HQKLAVLTFQENLIQ	FAM135B	356	Q49AJ0
QLHQVIVARFADDQL	CAPN2	641	P17655
IAESIQHLASLQIFI	LRRC30	201	A6NM36
VIENHILKLFQSNLV	RFXANK	241	O14593
ADLRQLVTEHAQLVQ	PPARA	431	Q07869
AISVLHEVIQQTFNL	IFNA6	76	P05013
LVLQQELEFHTEELQ	PMFBP1	91	Q8TBY8
NIQSHLGEALIQDLI	PMM2	86	O15305
TFNIEIENAQHLKLV	SYDE2	731	Q5VT97
TLKNHFQSVLEQLEL	TAF7L	426	Q5H9L4
SRFHELQLQLEQLTI	TCP11L1	331	Q9NUJ3
LQQELLINITEHELV	POLR2E	131	P19388
LVNHVNIRLQAELEE	SMG5	391	Q9UPR3
QSVVAEHQQFDELLL	SYNE1	1761	Q8NF91
ENQLALELSQHEVFV	ARHGAP17	101	Q68EM7
LAEQLHQADLEQALL	NBEAL2	66	Q6ZNJ1
SQQLVHVTVINLFQL	SMG7	291	Q92540
GVLEHLNAIVQIDLN	SLITRK3	546	O94933
NHNVVRELDISQLLL	RNF215	161	Q9Y6U7
TQITNLDLQHNELLD	SHOC2	261	Q9UQ13
NINAILLLAVVVFIH	SLC5A4	641	Q9NY91
HLQINQTFEELRLVT	STAT5B	141	P51692
QLEEVILQAEHELNL	NDUFA5	76	Q16718
HLQINQTFEELRLVT	STAT5A	141	P42229
FTQFLLEIQLEHAKQ	SLC25A13	151	Q9UJS0
QQFLILRLEDHASNV	CHST15	471	Q7LFX5
QEEITHLLSQIVDLQ	TRAK1	281	Q9UPV9
NLRVLHLEDNQVSVI	SLIT3	86	O75094
THVFVIAELVNVLQE	GTF2H5	41	Q6ZYL4
NTFLDLTVQQIEHLN	UGP2	136	Q16851
VLGLLNNIAEVQELH	ZYG11B	561	Q9C0D3
LQQLRLEHEVAATQL	TEX13D	111	A0A0J9YY54
NLIVQHIQDILNGDI	UCK1	221	Q9HA47
LIQALEEVQEFHQLE	WASHC5	501	Q12768
VEDVVHTQLINLLQQ	SUPT3H	51	O75486
QHLFCLIRVIQTEAQ	RLF	351	Q13129
HLELFLQQLQEVVVK	STAG3	621	Q9UJ98
AVLAVFENIHVNEQL	SLC9A2	221	Q9UBY0
EAHLRLLLQQVASQE	SMC1B	996	Q8NDV3
VRVALQLSLHEDINQ	STAG3L4	106	Q8TBR4
IFIAAEITLHLQQLS	ZBED8	441	Q8IZ13
NVVLFDIFVNILTHN	NRDC	721	O43847
ILLKNFVELISHQQL	TEX10	181	Q9NXF1
LQQLRLEHEEVATQL	TEX13C	111	A0A0J9YWL9
QQVVIEFILNHVDQI	ARHGAP31	201	Q2M1Z3
LVNISHLNLVAFQEE	PLCB1	111	Q9NQ66
VLHALLENVLQDNID	SLF1	446	Q9BQI6
EIQLLVTDSVHNINF	ZBTB24	551	O43167
QNINLFVVDEVHLIG	SNRNP200	1446	O75643
FFLSVAQVQLLHQLI	VPS13B	1736	Q7Z7G8
IQELLNCTDIIFTHI	SCN11A	1086	Q9UI33
NLQIQHIDARFAVLL	TASOR2	2376	Q5VWN6
LQNVHLVFENSVEDI	THBS2	206	P35442
VLQEQVAHITEFNII	VWA3B	166	Q502W6
VDDIHFLVLQNLIQS	GTF3C1	1421	Q12789
ITLNEIQAQLEQHDI	TXLNG	246	Q9NUQ3
VQVEAQYILIHQALV	PTPRC	896	P08575
QHDVQELNRILFSAL	USP40	131	Q9NVE5
EHNLQLLIDLTEQEI	TFIP11	321	Q9UBB9
DQVFALIENLTHQIR	PPIP5K1	676	Q6PFW1
VVAFIQHFTQLQDVL	VPS13D	1986	Q5THJ4
INDILKHFQEELLSQ	VPS13D	4046	Q5THJ4
AIESQLQLHGLNIEE	KYNU	171	Q16719